8 April 2022; Company Announcement – Inova Health System – Acrobat pdf 90k


  • PME signs 8-year, AUD $32M deal with Inova Health System
  • Visage to replace two legacy PACS systems
  • Contract to include Fairfax Radiology – a joint venture between Fairfax Radiological Consultants. and Inova Health System
  • Visage 7 platform to be implemented in the public cloud
  • Extends PME’s rapidly growing footprint in the North American Integrated Delivery Network (IDN) market
  • Transaction-based model with potential upside

Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has signed a $32M, 8-year contract with Inova Health System, the leading nonprofit healthcare provider in Northern Virginia.

Inova’s 20,000+ team members provide more than two million patient visits each year through an integrated network of hospitals, primary and specialty care practices, emergency and urgent care centers, outpatient services and destination institutes.

Based on a transactional licensing model, the contract will see the company’s Visage 7 Enterprise Imaging Platform (“Visage 7”) implemented throughout Inova and Fairfax Radiology, providing a unified diagnostic imaging platform across both networks.

Planning for the rollout is to commence immediately, with initial go-lives targeted for the second half of the calendar year. The implementation will be fully deployed in the public cloud.

“This is our fourth major contract in the IDN space in less than 18 months which further underpins the strong momentum we continue to build not only in this segment of market but also the North American market as a whole,” said Dr Sam Hupert, Pro Medicus CEO.

Inova also joins an increasing number of Visage clients to opt for a fully cloud-deployed solution, a trend that has taken a foothold in the global healthcare IT market.

“Our pipeline remains strong. Deals like this confirm our view that Visage 7, with its proven cloud-native technology provides us with a significant strategic advantage that addresses these opportunities across a growing segment of the market both in North America and other regions.”